Dynamic Changes of Sp6 Transgene Expression in Dental Epithelial Cells during Long-term Culture

https://doi.org/10.22146/theindjdentres.10009

Trianna W. Utami(1*), Keiko Miyoshi(2), Hiroko Hagita(3), Ryna D. Yanuaryska(4), Taigo Horiguchi(5), Takafumi Noma(6)

(1) 
(2) 
(3) 
(4) 
(5) 
(6) 
(*) Corresponding Author

Abstract


To investigate the function of specificity protein 6 (SP6) transcription factor by gain-of-function procedure, we established cytomegalovirus (CMV) promoter-driven Sp6 stable transformants, C9 cells, using dental epithelialderived cells. Initially, C9 cells produced a significant amount of SP6 protein. However, SP6 expression was reduced in these cells upon long-term culture. We could detect Sp6 transcripts in C9 cells by RT-PCR throughout the passages, although the CMV promoter is known to be epigenetically silenced. We recently found that SP6 was a short-lived protein that was degraded by a ubiquitin-independent proteasome pathway, although it is yet unclear how Sp6 expression was regulated during culture. Thus, we studied the possibility of epigenetic regulation of Sp6 expression. Comparative analysis of endogenous and exogenous Sp6 mRNA expressions demonstrated the specific down-regulation of exogenous Sp6 mRNA levels during culture passages. A DNA methyltransferase inhibitor, 5-Aza-2'-deoxycytidine (5AC), and a histone deacetylase inhibitor, valproic acid (VPA), enhanced or induced SP6 protein expression up to passage 28 without enhancing the mRNA level. The dramatic up-regulation of exogenous Sp6 mRNA was uniquely observed only at passage 50 by 5AC or VPA treatment. These findings indicate that multiple epigenetic regulatory mechanisms operate to fine-tune Sp6 expression during long-term culture.

Keywords


DNA methylation; epigenetic regulation; gain-of-function; histone modification; Sp6

Full Text:

PDF


References

Thesleff I. 2003. Epithelial-mesenchymal signal- ling regulating tooth morphogenesis. J Cell Sci,116:1647-1648.

Brook AH. 2009. Multilevel complex interaction between genetic, epigenetic and environmental factors in the aetiology of anomalies of dental development. Arch Oral Biol, 54 Suppl 1:S3- S17.

Thesleff I. 2006. The genetic basis of tooth de- velopment and dental defects. Am J Med Genet A, 140:2530-2535

Jimenez-Rojo L, Ibarretxe G, Aurrekoetxea M, de Vega S, Nakamura T, Yamada Y, and Unda F. 2010. Epiprofin/Sp6: a new player in the regula- tion of tooth development. Histol Histopathol, 25:1621-1630.

Suske G, Bruford E, and Philipsen S. 2005. Mam- malian SP/KLF transcription factors: Bring in the family. Genomics, 85:551-556.

Scohy S, Gabant P, Van Reeth T, Herveldt V, Dr- eze PL, Van Vooren P, Riviere M, and Szpirer C. 2000. Identification of KLF13 and KLF14 (Sp6), novel members of the Sp6/XKLF transcription factor family. Genomics, 70:93-101.

Nakamura T, Unda F, de-Vega S, Vilaxa A, Fuku- moto S, Yamada KM, and Yamada Y. 2004. The Kruppel-like factor epiprofin is expressed by ep- ithelium of developing teeth, hair follicles, and limb buds and promotes cell proliferation. J Biol Chem, 279:626-634.

Bei M. 2009. Molecular genetics of ameloblast cell lineage. J Exp Zool B Mol Dev Evol, 312B:437-444.

Nakamura T, de Vega S, Fukumoto S, Jimenez L, Unda F, and Yamada T. 2007. Transcription fac- tor epiprofin is essential for tooth morphogen- esis by regulating epithelial cell fate and tooth number. J Biol Chem, 283:4825-4833.

Hertveldt V, Lourya S, Van Reeth T, Drèze P, Van Vooren P, Szpirer J, and Szpirer C. 2008. TThhee ddee- velopment of several organs and appendages is impaired in mice lacking Sp6. Dev Dyn, 237:883-892.

Ruspita I, Miyoshi K, Muto T, Abe K, Horiguchi T, and Noma T. 2008. Sp6 down regulation of follistatin gene expression in ameloblast. J Med Invest, 55:87-98

Wahyudi IA, Horiguchi T, Miyoshi K, Muto T, Utami TW, Hagita H, and Noma T. 2010. IIssoollaa- tion and characterization of mouse specificity protein 6 promoter. Indones J Den Res, 1:21-34.

Miyoshi K, Nagata H, Horiguchi T, Abe K, Wahyu- di IA, Baba Y, Harada H, and Noma T. 2008. BMP2-induced gene profiling in dental epithe- lial cell line. J Med Invest, 55:216-226

Utami TW, Miyoshi K, Hagita H, Yanuaryska RD, Horiguchi T, and Noma T. 2011. Possible linkage of SP6 transcriptional activity with amelogene- sis by protein stabilization. J BiomedBiotechnol, doi:10.1155/2011/320987.

Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, and Otterson GA. 2001. Increased expression of unmethylat- ed CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Oncogene, 20:7787-7796.

Marks PA and Xu WS. 2009. Histone deacetylase inhibitors: Potential in cancer therapy. J Cell Bio- chem, 107:600-608.

Abe K, Miyoshi K, Muto T, Ruspita I, Horiguchi T, Nagata T, and Noma T. 2007. Establishment and characterization of rat dental epithelial de- rived ameloblast-lineage clones. J Biosci Bioeng.103:479-485.

Grassi G, Maccaroni P, Meyer R, Kaiser H, Am- brosio ED, Pascale E, Grassi M, Kuhn A, Nardo PDi, Kandolf R, and Kupper JH. 2003. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. Carcinogenesis, 24:1625-1635.

Nan X, Campoy FJ, and Bird A. 1997. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell,88:471-481.

Forneris F, Binda C, Vanoni MA, Battaglioli E, and Mattevi A. 2005. Human histone demethylase LSD1 reads the histone code. J Biol Chem.280:41360-41365

Ben-Porath I and Cedar H. 2001. Epigenetic crosstalk. Mol Cell,8:933-935.

Vaissière T, Sawan C, and Herceg Z. 2008. Epige- netic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res, 659:40-48.

Chen WY, Bailey EC, McCune SL, Dong JY, and Townes TM. 1997. Reactivation of silenced, vi- rally transduced genes by inhibitors of histone deacetylase. Proc Natl Acad Sci USA, 94:5798-5803.

Hsu CC, Li HP, Hung YH, Leu YW, Wu WH, Wang FS, Lee KD, Chang PJ, Wu CS, Lu YJ, Huang THM, Chang YS, and Hsiao SH. 2010. Targeted methy- lation of CMV and E1A viral promoters. Biochem Biophys Res Commun, 402:228-234.

Mehta AK, Majumdar SS, Alam P, Gulati N, and Brahmacari V. 2009. Epigenetic regulation of cy- tomegalovirus major immediate-early promoter activity in transgenic mice. Gene, 428:20-24.

Yoo YG, Kong G, and Lee MO. 2006. Metastasis- associated protein 1 enhances stability of hypoxia-inducible factor-1 alpha protein by recruiting histone deacetylase 1.EMBO J,25:1231-1241.

Egger G, Liang G, Aparicio A, and Jones PA. 2004. Epigenetics in human disease and prospects for epigenetic therapy. Nature,429:457-463.

Herveldt V, De Mees C, Scohy S, Van Vooren P, Szpirer J, and Szpirer C. 2007. The Sp6 locus uses several promoters and generates sense and an- tisense transcripts. Biochimie, 89:1381-1387.

Feng YQ, Desprat R, Fu H, Olivier E, and Lin CM. 2006. DNA methylation supports intrinsic epigenetic memory in mammalian cells. Plos Genetics, 2:e65 doi:10.1371/journal.pgen.0020065



DOI: https://doi.org/10.22146/theindjdentres.10009

Article Metrics

Abstract views : 812 | views : 529

Refbacks

  • There are currently no refbacks.






  
   

 

 

 

website statistics

 

View My Stats